(Q35642522)

9 August 2017

1 reference

title

The imaging of apoptosis with the radiolabeled annexin V: optimal timing for clinical feasibility (English)

1 reference

9 August 2017

Tarik Belhocine

1

1 reference

9 August 2017

Neil Steinmetz

2

1 reference

9 August 2017

Chun Li

3

1 reference

9 August 2017

Allan Green

4

1 reference

9 August 2017

Francis G Blankenberg

5

1 reference

9 August 2017

publication date

1 February 2004

1 reference

Technology in Cancer Research and Treatment

9 August 2017

published in

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

23-32

1 reference

Clinical trial design for target-based therapy

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Challenges of PK/PD measurements in modern drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Monitoring apoptosis in real time

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

In vivo detection and imaging of phosphatidylserine expression during programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Apoptosis induced by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Induction of apoptosis by cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Apoptosis and the response to anticancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human use

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Improved radiolabeling of PEGylated protein: PEGylated annexin V for noninvasive imaging of tumor apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Iodine-124 labelled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Apoptosis. Its significance in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Dysregulation of apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Apoptotic cell death: its implications for imaging in the next millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Apoptosis: the importance of nuclear medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Transbilayer movement of phospholipids in red cell and platelet membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Apoptosis in squamous cell carcinoma of the lung: correlation with survival and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Advancing animal models of neoplasia through in vivo bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Use of reporter genes for optical measurements of neoplastic disease in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

The role of the macrophage in apoptosis: hunter, gatherer, and regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Early stages of p53-induced apoptosis are reversible

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Delayed expression of apoptosis in human lymphoma cells undergoing low-dose taxol-induced mitotic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Biodistribution and dosimetry of (99m)Tc-BTAP-annexin-V in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

Methods utilized in the study of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460400300103

10.1177/153303460400300103

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference